METHYLPHENIDATE and OFF LABEL USE

Overview

OFF LABEL USE is the #2 most commonly reported adverse reaction for METHYLPHENIDATE, manufactured by Noven Therapeutics, LLC. There are 5,881 FDA adverse event reports linking METHYLPHENIDATE to OFF LABEL USE. This represents approximately 9.3% of all 63,290 adverse event reports for this drug.

Patients taking METHYLPHENIDATE who experience off label use should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

OFF LABEL USE5,881 of 63,290 reports

OFF LABEL USE is moderately reported among METHYLPHENIDATE users, representing a notable but not dominant share of adverse events.

Other Side Effects of METHYLPHENIDATE

In addition to off label use, the following adverse reactions have been reported for METHYLPHENIDATE:

NO ADVERSE EVENT — 6,875 reports
PRODUCT QUALITY ISSUE — 5,241 reports
DRUG INEFFECTIVE — 2,873 reports
DRUG ADMINISTRATION ERROR — 1,901 reports
WRONG TECHNIQUE IN DRUG USAGE PROCESS — 1,772 reports
APPLICATION SITE ERYTHEMA — 1,684 reports
DRUG DOSE OMISSION — 1,478 reports
INCORRECT DRUG ADMINISTRATION DURATION — 1,191 reports
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS — 1,133 reports
DRUG PRESCRIBING ERROR — 1,079 reports

Other Drugs Associated with OFF LABEL USE

The following drugs have also been linked to off label use in FDA adverse event reports:

0XYGEN ABACAVIR SULFATE ABATACEPT ABIRATERONE ACETATE ACALABRUTINIB ACETAMINOPHEN ACETAMINOPHEN 500MG ACETAMINOPHEN AND CODEINE ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE ACETAMINOPHEN AND IBUPROFEN ACETAMINOPHEN AND PHENYLEPHRINE HYDROCHLORIDE ACETAMINOPHEN, ASPIRIN, AND CAFFEINE ACETAMINOPHEN, ASPIRIN, CAFFEINE ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE ACETAMINOPHEN, CAFFEINE ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, AND PHENYLEPHRINE HYDROCHLORIDE ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE ACETAMINOPHEN, IBUPROFEN

Does METHYLPHENIDATE cause OFF LABEL USE?

OFF LABEL USE has been reported as an adverse event in 5,881 FDA reports for METHYLPHENIDATE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is OFF LABEL USE with METHYLPHENIDATE?

OFF LABEL USE accounts for approximately 9.3% of all adverse event reports for METHYLPHENIDATE, making it one of the most commonly reported side effect.

What should I do if I experience OFF LABEL USE while taking METHYLPHENIDATE?

If you experience off label use while taking METHYLPHENIDATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.